Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 28, 2024 (Week 39) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 41 NC 3,095 4,962 New England 1 NC 49 77 Connecticut - NC - - Maine - NC 10 37 Massachusetts - NC - - New Hampshire - NC 13 18 Rhode Island - NC 25 21 Vermont 1 NC 1 1 Middle Atlantic 1 NC 113 420 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 178 Pennsylvania 1 NC 113 242 East North Central 25 NC 1,545 1,981 Illinois - NC 22 554 Indiana - NC 213 289 Michigan - NC 135 248 Ohio 25 NC 1,054 859 Wisconsin - NC 121 31 West North Central - NC 112 203 Iowa - NC 46 70 Kansas - NC 62 67 Minnesota - NC - 56 Missouri - NC - - Nebraska - NC - - North Dakota - NC - 9 South Dakota - NC 4 1 South Atlantic 14 NC 424 635 Delaware - NC 15 12 District of Columbia - NC - - Florida N NC N N Georgia - NC - 240 Maryland - NC - - North Carolina - NC - 127 South Carolina - NC - - Virginia 14 NC 336 188 West Virginia - NC 73 68 East South Central - NC 60 162 Alabama N NC N N Kentucky - NC - - Mississippi - NC 60 162 Tennessee - NC - - West South Central - NC - 18 Arkansas - NC - - Louisiana - NC - 18 Oklahoma - NC - - Texas U NC U U Mountain - NC 775 755 Arizona - NC 726 611 Colorado - NC - - Idaho - NC - - Montana - NC 8 1 Nevada - NC 2 84 New Mexico - NC - - Utah - NC 39 58 Wyoming - NC - 1 Pacific - NC 17 711 Alaska - NC - - California - NC - 608 Hawaii - NC - 15 Oregon - NC 17 22 Washington - NC - 66 U.S. Territories - NC - 136 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 136 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC 2 - Total 41 NC 3,097 5,098 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.